You are here: Industry Insights > pathway

News List

The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial prnasia
June 04, 2021
June 1 is World Hypopara Awareness Day. VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs, announced that it has obtained the investigational new drug (IND) approval from the ...
Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials pharmafocusasia
March 12, 2019
Envigo, a leading provider of non-clinical contract research services and research models, announced today the launch of PATHWAY – an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials.
FDA drafts pathway for digital health innovations firstwordpharma
January 09, 2019
The FDA announced that it has drafted a regulatory framework to test new approaches for the review of digital health device applications. The framework is based on the Digital Health Precertification (Pre-Cert) programme that was piloted after the agency